TGen and ABL pursue global rollout of advanced TB test Posted Monday March 18, 2019 Licensing agreement puts DeepChek®-TB one step closer to clinical application
Flinn Foundation awards ‘Prevent HAARM’ grant to C-Path and TGen Posted Tuesday January 8, 2019 $400,000 grant aims to develop a genomic surveillance system to respond to antimicrobial resistant pathogens
TGen sequencing test enables precise identification of drug-resistant TB Posted Monday October 9, 2017 UCSF and TGen researchers advance SMOR testing, with an eye on precision medicine for tuberculosis
Two Arizona leaders in scientific collaboration partner to advance global TB research Posted Monday May 1, 2017 TGen and Critical Path Institute receive Gates Foundation award to create genomic-based treatments tailored to individual patients